Genico Pharma Private Limited - Company Profile

It is a trading private limited company based in Thane, Maharashtra, India, established in 2021.
2021 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Genico Pharma Private Limited

Genico Pharma Private Limited, a active private limited company, was established on 10 June 2021 in Thane, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2021PTC361921. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Saba Sameer Dosani (Director), Shreyash Sanjay Tripathi (Director). Past directors included Rajesh Mangesh Talvekar, Mukesh Ramkumar Vishwakarma. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 503, Golden Valley A, Wing, Mira Bhaindar Rd, Opp Goyal Plaza,, Thane, Maharashtra, 401107.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2021PTC361921

  • Registration Number

    361921

  • Incorporation Date

    10 June 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 26 Days
  • Last Filing with ROC 31 Mar 2022
Company report

Genico Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Genico Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genico Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Saba Sameer Dosani Director 05 Dec 2022 Current
Shreyash Sanjay Tripathi Director 05 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Dec 2022 Past
Pramod Abcsdd Director 05 Dec 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genico Pharma.

Enhance accessibility to Genico Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Genico Pharma revenue growth over time
Genico Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genico Pharma?

Unlock access to Genico Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Genico Pharma?

Genico Pharma has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genico Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genico Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genico Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Saba Sameer Dosani was appointed as a Director was appointed as a Director on 05 Dec 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    Progress on Shreyash Sanjay Tripathi was appointed as a Director was appointed as a Director on 05 Dec 2022 & has been associated with this company since 3 years 7 months . was documented.

  • Annual General Meeting

    The activity Genico Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Genico Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai Ii. was completed.

  • Company Incorporation

    Progress on Genico Pharma Private Limited was registered on 10 Jun 2021 with Roc Mumbai Ii & aged 5 years 26 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genico Pharma Private Limited?

The CIN of Genico Pharma Private Limited is U51909MH2021PTC361921.

Where is Genico Pharma Private Limited headquartered?

Genico Pharma Private Limited is headquartered at 503, Golden Valley A, Wing, Mira Bhaindar Rd, Opp Goyal Plaza,, Thane, Maharashtra, 401107.

When was Genico Pharma Private Limited incorporated?

Genico Pharma Private Limited was incorporated on 10 June 2021.

Who are the current directors of Genico Pharma Private Limited?

The current directors of Genico Pharma Private Limited are

What is the primary industry of Genico Pharma Private Limited?

The primary industry of Genico Pharma Private Limited is Trading.

Is Genico Pharma Private Limited a listed company?

Genico Pharma Private Limited is unlisted.

What is the capital structure of Genico Pharma Private Limited?

The authorized capital of Genico Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available